8-K
filed August 15, 2022, 7:59 PM ET
ticker BGLC
CIK 0001737523
leadership
confidence high
sentiment neutral
materiality 0.75
Bionexus Gene Lab replaces Chairman, CEO, and President in leadership reshuffle
BioNexus Gene Lab Corp
- Chairman Soo Kow Lai, CEO Chan Chong Wong, and President Chi Yuen Leong resigned effective Aug 12, 2022; no disagreement cited.
- Yeat Min Fong appointed Chairman, Sook Keng Yeoh CEO, Yee Meng Wong President, effective Aug 9, 2022.
- Each new officer receives $12,000 annual salary and 25,000 common shares under employment agreements.
- Fong has 15+ years in medical industry; Yeoh 41 years in management; Wong biochem background with 10+ years research.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Soo Kow Lai resigned as Chairman at BioNexus Gene Lab Corp.
- Action
- resigned
- Role
- Chairman
Exact text from the filing
On August 9, 2022, Mr. Soo Kow Lai, the Chairman and director, Mr. Chan Chong Wong, the Chief Executive Officer and director, and Mr. Chi Yuen Leong, the President and director, notified Bionexus Gene Lab Corp (“the Company”) their desire to resign from their positions at the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Yee Meng Wong was appointed as President at BioNexus Gene Lab Corp.
- Action
- appointed
- Role
- President
Exact text from the filing
On August 9, 2022, the Board of Directors of the Company approved the appointments of Mr. Yeat Min Fong as the Chairman and director, Mr. Sook Keng Yeoh as the Chief Executive Officer and director, and Ms. Yee Meng Wong as the President and director, effective August 9, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Chan Chong Wong resigned as Chief Executive Officer at BioNexus Gene Lab Corp.
- Action
- resigned
- Role
- Chief Executive Officer
Exact text from the filing
On August 9, 2022, Mr. Soo Kow Lai, the Chairman and director, Mr. Chan Chong Wong, the Chief Executive Officer and director, and Mr. Chi Yuen Leong, the President and director, notified Bionexus Gene Lab Corp (“the Company”) their desire to resign from their positions at the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Chi Yuen Leong resigned as President at BioNexus Gene Lab Corp.
- Action
- resigned
- Role
- President
Exact text from the filing
On August 9, 2022, Mr. Soo Kow Lai, the Chairman and director, Mr. Chan Chong Wong, the Chief Executive Officer and director, and Mr. Chi Yuen Leong, the President and director, notified Bionexus Gene Lab Corp (“the Company”) their desire to resign from their positions at the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sook Keng Yeoh was appointed as Chief Executive Officer at BioNexus Gene Lab Corp.
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
On August 9, 2022, the Board of Directors of the Company approved the appointments of Mr. Yeat Min Fong as the Chairman and director, Mr. Sook Keng Yeoh as the Chief Executive Officer and director, and Ms. Yee Meng Wong as the President and director, effective August 9, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Yeat Min Fong was appointed as Chairman at BioNexus Gene Lab Corp.
- Action
- appointed
- Role
- Chairman
Exact text from the filing
On August 9, 2022, the Board of Directors of the Company approved the appointments of Mr. Yeat Min Fong as the Chairman and director, Mr. Sook Keng Yeoh as the Chief Executive Officer and director, and Ms. Yee Meng Wong as the President and director, effective August 9, 2022.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.